- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Supreme Announces Conditional Approval to List on the TSXV
Supreme Pharmaceuticals (CSE:SL) has announced it has received conditional approval from the TSX Venture Exchange to list its shares on the TSXV. As quoted in the press release: John Fowler, President and CEO, stated: “Graduating from the CSE to the TSX.V is an important milestone for Supreme. We enjoyed tremendous success throughout our time on …
Supreme Pharmaceuticals (CSE:SL) has announced it has received conditional approval from the TSX Venture Exchange to list its shares on the TSXV.
As quoted in the press release:
John Fowler, President and CEO, stated: “Graduating from the CSE to the TSX.V is an important milestone for Supreme. We enjoyed tremendous success throughout our time on the CSE, which provided us the flexibility we needed in the early stages of our growth. Graduating to the TSX.V prepares us for the next steps in the development of our cannabis business.”
The Company would like to thank the CSE for its role in Supreme’s success over the past three years.
Final approval of listing on the TSX.V is subject to Supreme satisfying certain customary conditions required by the TSX.V. Supreme expects that it will be able to satisfy all such conditions by mid-May 2017 and will provide an update once the TSX.V has issued a bulletin confirming the date on which trading on the TSX.V will commence. Following completion of all listing requirements, Supreme’s common shares will be voluntarily delisted from the Canadian Securities Exchange and will begin trading on the TSX.V under a new symbol.
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.